Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$5.01 USD
+0.46 (10.11%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.99 -0.02 (-0.40%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.74 | 0.00% |
Earnings Summary
For their last quarter, Sutro Biopharma (STRO) reported earnings of -$0.59 per share, beating the Zacks Consensus Estimate of $-0.76 per share. This reflects a positive earnings surprise of 22.37%. Look out for STRO's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.74 per share, reflecting a year-over-year increase of 8.64%.
Earnings History
Price & Consensus
Zacks News for STRO
XOMA Royalty (XOMA) Reports Q2 Loss, Tops Revenue Estimates
STRO: What are Zacks experts saying now?
Zacks Private Portfolio Services